Towards clinical applications of blood-born miRNA signatures: The influence of the anticoagulant EDTA on miRNA abundance
Ontology highlight
ABSTRACT: Circulating microRNAs (miRNAs) from blood are increasingly recognized as biomarker candidates for human diseases. Clinical routine settings frequently include blood sampling in tubes with EDTA as anticoagulant without considering the influence of phlebotomy on the overall miRNA expression pattern. We collected blood samples from six healthy individuals each in an EDTA blood collection tube. Subsequently, the blood was transferred into PAXgeneTM tubes at three different time points, i.e. directly (0 min), 10 min, and 2 h after phlebotomy. As control blood was also directly collected in PAXgeneTM blood RNA tubes that contain a reagent to directly lyse blood cells and stabilize their content. For all six blood donors at the four conditions (24 samples) we analyzed the abundance of 1,205 miRNAs by human Agilent miRNA V16 microarrays.
ORGANISM(S): Homo sapiens
PROVIDER: GSE73401 | GEO | 2015/12/31
SECONDARY ACCESSION(S): PRJNA296893
REPOSITORIES: GEO
ACCESS DATA